Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians - The Lancet

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians  The Lancet

Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network